Thomas J. Lynch Jr.

Insider Reports History

Location
New Haven, CT
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Thomas J. Lynch Jr.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas J. Lynch Jr.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Director Stock Option (right to buy) 25,000 $119,750 $4.79 17 Jun 2025 Direct

Insider Reports Filed by Thomas J. Lynch Jr.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FHTX Foghorn Therapeutics Inc. 17 Jun 2025 1 +$119,750 4 Director 17 Jun 2025, 16:28
FHTX Foghorn Therapeutics Inc. 26 Jun 2024 1 +$88,320 4 Director 28 Jun 2024, 16:06
FHTX Foghorn Therapeutics Inc. 21 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:14
FHTX Foghorn Therapeutics Inc. 27 Oct 2022 1 +$263,360 4 Director 31 Oct 2022, 16:04
FHTX Foghorn Therapeutics Inc. 27 Oct 2022 0 $0 3 Director 31 Oct 2022, 16:01